Evidence map›Paper›PMID 41878514›Full record

ArticleMycology2026

Minutellins E-I and daldinone L, new secondary metabolites from different species of the Hypoxylaceae (Xylariales, Ascomycota).

Christopher Lambert, Mohammad Javad Pourmoghaddam, Esteban Charria-Girón, Frank Surup, Seyed Akbar Khodaparast, Hermann Voglmayr, Irmgard Krisai-Greilhuber, Marc Stadler

Abstract read
In one paragraph

Article in Mycology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christopher LambertMicrobial Drugs, Helmholtz-Centre for Infection Research GmbH, Braunschweig, Germany.ORCID https://orcid.org/0000-0002-1899-8214
Mohammad Javad PourmoghaddamDepartment of Plant Protection, Faculty of Agricultural Sciences, University of Guilan, Rasht, Iran.ORCID https://orcid.org/0000-0001-6055-7503
Esteban Charria-GirónMicrobial Drugs, Helmholtz-Centre for Infection Research GmbH, Braunschweig, Germany.ORCID https://orcid.org/0000-0002-3823-1416
Frank SurupMicrobial Drugs, Helmholtz-Centre for Infection Research GmbH, Braunschweig, Germany.ORCID https://orcid.org/0000-0001-5234-8525
Seyed Akbar KhodaparastDepartment of Plant Protection, Faculty of Agricultural Sciences, University of Guilan, Rasht, Iran.ORCID https://orcid.org/0000-0002-7480-4170
Hermann VoglmayrDepartment of Botany and Biodiversity Research, University of Vienna, Wien, Austria.ORCID https://orcid.org/0000-0001-7666-993X
Irmgard Krisai-GreilhuberDepartment of Botany and Biodiversity Research, University of Vienna, Wien, Austria.ORCID https://orcid.org/0000-0003-1078-3080
Marc StadlerMicrobial Drugs, Helmholtz-Centre for Infection Research GmbH, Braunschweig, Germany.ORCID https://orcid.org/0000-0002-7284-8671

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fungi of the family Hypoxylaceae (Xylariales, Ascomycota) are ubiquitously distributed and fulfil important ecological roles as saprobes, pathogens, and endophytes. Members of this family tend to store large amounts of secondary metabolites in their carbonaceous stromatal tissue commonly formed on colonised wood. This feature is of both taxonomic and chemical value by serving as chemotaxonomic markers and sources of potential new and bioactive compounds. Despite tremendous progress in the characterisation of Hypoxylaceae both in terms of genomics and secondary metabolomics, many unknown metabolites remain to be identified or elucidated. Here, we report on the polyphasic, i.e. morphological, chemical, and genetical analysis of

Indexed as

Azaphilonesmolecular phylogenysecondary metabolitesstructure elucidationtaxonomy

Identifiers

PMID41878514
PMCPMC13007406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.